Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue April 2015
 •  OPI To Debut ColorPaints  •  Sales Jump 14% at CCA Industries  •  ISSA Revamps Clean Standard  •  Unilever Kicks Off Q1 With Gains  •  Q Laboratories, Inc. Hires Lemp
Print

Fuji Chemical Granted Inflammation Patent



Published September 8, 2006
Related Searches: patent ink eye industry
Post a comment
Patent No. US 7,078,040 B2: Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ has been granted a patent for inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin. Fuji’s pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia.



blog comments powered by Disqus